Don't miss! In this DeviceTalks podcast hosted by Tom Salemi, Fogarty CEO Andrew Cleeland shares insights on leading a medtech startup, his concerns for the industry at large, and details about the inaugural Thomas J. Fogarty Innovation Prize, which recognizes an innovator or team who has developed and brought to market a life-changing medical technology. Thank you for the conversation, Tom! (fb)

Medtech VC perspectives and advice from our recent Fundraising Workshop. Thank you Christopher Shen, Susan Stimson, and Cynthia Yee for sharing thoughtful insights about the entire process - from making a connection to closing the deal. 🤝 Networking and personal connections are key to finding and connecting with investors. Warm intros and referrals from trusted sources like friends and KOLs carry the most weight. 🤝The biggest factor in securing a meeting is whether your company aligns with the fund's sector and investment strategy. For a reality check, look at the portfolio companies listed on the VC’s website. 🤝 In the meeting, explain why your market and technology are compelling. Cover reimbursement, clinical trial strategy, and exit strategy, and leave enough time to discuss financing. Pro tip – ask the VC team what they would like you to cover and adjust your presentation accordingly. 🤝 This is a long-term relationship, so make sure your team dynamics are seamless and engaging. Balance being confident and passionate with being open, humble, and responsive to feedback. Avoid defensiveness. 🤝Be prepared to provide investors with full transparency and access to information, even if it's not all perfectly polished. 🤝 When you know it’s a go: There’s a tipping point where a VC partner goes from being skeptic to a champion who is batting for you internally. When you see that shift, you should be working in concert with that person to get your deal over the finish line. (fb)